VAERS reports by lot

Moderna COVID-19 lot 051B22A: VAERS reports

155 VAERS reports list lot 051B22A as a Moderna COVID-19 vaccine, received between 2022-07-08 and 2023-11-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
155
Reports
7%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6221%
Neurological4415%
Cardiac / Cardiovascular4114%
Gastrointestinal3813%
Respiratory269%
Dermatological (non-injection-site)207%
Injection-site / Local reaction186%
Musculoskeletal155%
Thrombotic / Hematological124%
Allergic / Anaphylactic114%
Psychiatric / Neuropsychiatric41%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California34
New Mexico12
Texas8
Michigan7
Colorado6
Washington6
New York5
Missouri4
Oregon4
Florida4
Alabama3
New Jersey3

Reports by month received

2022-0725
2022-0831
2022-0925
2022-108
2022-116
2022-125
2023-0113
2023-023
2023-032
2023-0413
2023-082
2023-0914
2023-118

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.